Veracyte (VCYT) Equity Average (2013 - 2026)

Veracyte (VCYT) has 14 years of Equity Average data on file, last reported at $1.3 billion in Q1 2026.

• Quarterly Equity Average rose 11.94% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 11.94% YoY) and the FY2025 annual result came in at $1.2 billion, up 11.96% from the prior year.
• Equity Average climbed to $1.3 billion in Q1 2026 per VCYT's latest filing, from $1.3 billion in the prior quarter.
• The five-year high for Equity Average was $1.3 billion in Q1 2026, with the low at $1.0 billion in Q4 2023.
• Average Equity Average over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
• The widest YoY moves for Equity Average: up 56.34% in 2022, down 3.64% in 2022.
• Veracyte's Equity Average stood at $1.1 billion in 2022, then retreated by 1.19% to $1.0 billion in 2023, then rose by 12.1% to $1.2 billion in 2024, then climbed by 9.15% to $1.3 billion in 2025, then grew by 3.38% to $1.3 billion in 2026.
• Business Quant data shows VCYT's Equity Average at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.